Judith Bruchfeld

6.7k total citations · 1 hit paper
101 papers, 2.4k citations indexed

About

Judith Bruchfeld is a scholar working on Infectious Diseases, Epidemiology and Surgery. According to data from OpenAlex, Judith Bruchfeld has authored 101 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 75 papers in Infectious Diseases, 58 papers in Epidemiology and 39 papers in Surgery. Recurrent topics in Judith Bruchfeld's work include Tuberculosis Research and Epidemiology (70 papers), Mycobacterium research and diagnosis (34 papers) and Pneumocystis jirovecii pneumonia detection and treatment (20 papers). Judith Bruchfeld is often cited by papers focused on Tuberculosis Research and Epidemiology (70 papers), Mycobacterium research and diagnosis (34 papers) and Pneumocystis jirovecii pneumonia detection and treatment (20 papers). Judith Bruchfeld collaborates with scholars based in Sweden, China and Australia. Judith Bruchfeld's co-authors include Gunilla Källenius, Margarida Correia‐Neves, Ingela Berggren Palme, Lina Davies Forsman, Getachew Aderaye, Lars Lindquist, Jerker Jonsson, Jan‐Willem C. Alffenaar, Bjarne Bjorvatn and Michael Runold and has published in prestigious journals such as Circulation, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Judith Bruchfeld

94 papers receiving 2.3k citations

Hit Papers

Long-Haul Post–COVID-19 Symptoms Presenting as a Variant ... 2021 2026 2022 2024 2021 40 80 120

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Judith Bruchfeld Sweden 27 1.8k 1.3k 893 256 176 101 2.4k
Inderpaul Singh Sehgal India 32 1.9k 1.1× 785 0.6× 385 0.4× 235 0.9× 86 0.5× 202 3.7k
Elizabeth Dufort United States 14 1.3k 0.7× 675 0.5× 713 0.8× 403 1.6× 207 1.2× 28 2.4k
Katharine A. Kirby United States 25 1.0k 0.6× 1.5k 1.1× 177 0.2× 220 0.9× 199 1.1× 54 2.8k
Ivan Gentile Italy 33 1.1k 0.6× 1.6k 1.2× 213 0.2× 235 0.9× 377 2.1× 202 3.3k
Clark D Russell United Kingdom 17 1.6k 0.9× 929 0.7× 245 0.3× 733 2.9× 281 1.6× 43 3.0k
Majid Marjani Iran 23 1.3k 0.7× 795 0.6× 419 0.5× 242 0.9× 128 0.7× 170 1.8k
Howard A. Zucker United States 16 1.6k 0.9× 484 0.4× 739 0.8× 418 1.6× 300 1.7× 31 2.6k
Patrick Mallon Ireland 38 2.2k 1.3× 804 0.6× 240 0.3× 138 0.5× 438 2.5× 198 4.2k
Brad Hutton United States 7 1.4k 0.8× 347 0.3× 697 0.8× 399 1.6× 190 1.1× 7 2.1k
Koichiro Kudo Japan 25 684 0.4× 708 0.5× 286 0.3× 115 0.4× 284 1.6× 138 2.2k

Countries citing papers authored by Judith Bruchfeld

Since Specialization
Citations

This map shows the geographic impact of Judith Bruchfeld's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Judith Bruchfeld with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Judith Bruchfeld more than expected).

Fields of papers citing papers by Judith Bruchfeld

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Judith Bruchfeld. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Judith Bruchfeld. The network helps show where Judith Bruchfeld may publish in the future.

Co-authorship network of co-authors of Judith Bruchfeld

This figure shows the co-authorship network connecting the top 25 collaborators of Judith Bruchfeld. A scholar is included among the top collaborators of Judith Bruchfeld based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Judith Bruchfeld. Judith Bruchfeld is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Conradsson, David Moulaee, et al.. (2025). Physical activity, sedentary time, and associated factors in post-COVID-19 condition: a cross-sectional study. Journal of Rehabilitation Medicine. 57. jrm43967–jrm43967.
2.
Folkesson, Elin, Gabrielle Fröberg, Christopher Sundling, et al.. (2025). Improved Detection of Extrapulmonary and Paucibacillary Pulmonary Tuberculosis by Xpert MTB Host Response in a Tuberculosis Low-Endemic, High-Resource Setting. The Journal of Infectious Diseases. 232(1). e78–e88. 1 indexed citations
3.
Kjellberg, Anders, Anna Schening, Jan Kowalski, et al.. (2025). Ten sessions of hyperbaric oxygen versus sham treatment in patients with long covid (HOT-LoCO): a randomised, placebo-controlled, double-blind, phase II trial. BMJ Open. 15(4). e094386–e094386. 1 indexed citations
4.
Holmström, Linda, David Moulaee Conradsson, Marcus Ståhlberg, et al.. (2024). Individually tailored exercise in patients with postural orthostatic tachycardia syndrome related to post-COVID-19 condition – a feasibility study. Scientific Reports. 14(1). 20017–20017. 3 indexed citations
5.
Forsman, Lina Davies, Jerker Jonsson, Ramona Groenheit, et al.. (2024). Increased risk of adverse drug reactions by higher linezolid dose per weight in multidrug-resistant tuberculosis. International Journal of Antimicrobial Agents. 64(4). 107302–107302. 5 indexed citations
6.
Forsman, Lina Davies, Sainan Wang, Shanshan Wang, et al.. (2024). Drug Exposure and Susceptibility of Pyrazinamide Correlate with Treatment Response in Pyrazinamide-Susceptible Patients with Multidrug-Resistant Tuberculosis. Pharmaceutics. 16(1). 144–144. 1 indexed citations
7.
Forsman, Lina Davies, Cheng Chen, Haoyue Zhang, et al.. (2024). Drug Exposure and Treatment Outcomes in Patients With Multidrug-Resistant Tuberculosis and Diabetes Mellitus: A Multicenter Prospective Cohort Study From China. Clinical Infectious Diseases. 79(2). 524–533. 4 indexed citations
8.
Ståhlberg, Marcus, Allan Z. Zhao, Artur Fedorowski, et al.. (2024). Post-Acute COVID-19 Syndrome: Prevalence of Peripheral Microvascular Endothelial Dysfunction and Associations With NT-ProBNP Dynamics. The American Journal of Medicine. 138(6). 1019–1028. 5 indexed citations
9.
Nickander, Jannike, Judith Bruchfeld, Michael Runold, et al.. (2023). Stress native T1 and native T2 mapping compared to myocardial perfusion reserve in long-term follow-up of severe Covid-19. Scientific Reports. 13(1). 4159–4159. 1 indexed citations
10.
Rodriguez, Lucie, Ziyang Tan, Tadepally Lakshmikanth, et al.. (2023). Immune system perturbations in patients with severe long COVID. The Journal of Immunology. 210(Supplement_1). 233.07–233.07. 2 indexed citations
11.
Mousavian, Zaynab, Elin Folkesson, Gabrielle Fröberg, et al.. (2022). A protein signature associated with active tuberculosis identified by plasma profiling and network-based analysis. iScience. 25(12). 105652–105652. 9 indexed citations
12.
Hedberg, Pontus, Fredrik Granath, Judith Bruchfeld, et al.. (2022). Post COVID‐19 condition diagnosis: A population‐based cohort study of occurrence, associated factors, and healthcare use by severity of acute infection. Journal of Internal Medicine. 293(2). 246–258. 41 indexed citations
13.
Kjellberg, Anders, Carl Johan Sundberg, John Pernow, et al.. (2022). Hyperbaric oxygen for treatment of long COVID-19 syndrome (HOT-LoCO): protocol for a randomised, placebo-controlled, double-blind, phase II clinical trial. BMJ Open. 12(11). e061870–e061870. 15 indexed citations
14.
Mahdi, Ali, Jannike Nickander, Artur Fedorowski, et al.. (2022). Abstract 12760: Microvascular Endothelial Dysfunction in Postural Orthostatic Tachycardia Syndrome Associated With Post-Acute Sequelae of COVID-19. Circulation. 146(Suppl_1). 1 indexed citations
15.
Hu, Yi, Xubin Zheng, Lina Davies Forsman, et al.. (2021). Emergence of additional drug resistance during treatment of multidrug-resistant tuberculosis in China: a prospective cohort study. Clinical Microbiology and Infection. 27(12). 1805–1813. 5 indexed citations
16.
Fröberg, Gabrielle, Margarida Correia‐Neves, Robert Szulkin, et al.. (2020). CD4+ T cell proliferative responses to PPD and CFP-10 associate with recent M. tuberculosis infection. Tuberculosis. 123. 101959–101959. 3 indexed citations
17.
Kulane, Asli, et al.. (2019). Quality of life of patients on treatment for latent tuberculosis infection: a mixed-method study in Stockholm, Sweden. Health and Quality of Life Outcomes. 17(1). 158–158. 11 indexed citations
18.
Sturkenboom, Marieke G. G., Samiksha Ghimire, Onno W. Akkerman, et al.. (2018). Mass spectrometry for therapeutic drug monitoring of anti-tuberculosis drugs. PubMed. 14. 34–45. 18 indexed citations
19.
Hamasur, Beston, Judith Bruchfeld, Melles Haile, et al.. (2001). Rapid diagnosis of tuberculosis by detection of mycobacterial lipoarabinomannan in urine. Journal of Microbiological Methods. 45(1). 41–52. 97 indexed citations
20.
Bruchfeld, Judith, et al.. (2000). [Extrapulmonary tuberculosis--an infection of concern in most clinical settings].. PubMed. 97(48). 5622–6. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026